Bringing the fundamentals into focus…
Back to argenx SE
How argenx SE stacks up
ARGX · against 55 other Healthcare companies of similar size
Growth
96/ 100
Near the top of its peers.
Ranked #1 of 56 · scores higher than 100% of peers
Bars: peers in each 10-point band of the growth score2 peers with a growth score of 90–100, including ARGX · Click a bar to see the companies
Why growth scores 96?
Weighted metrics compared with all Healthcare companies.Mainly thanks to its 3-year revenue growth, revenue growth and earnings per share growth, which are stronger than most Healthcare peers.
- faster growth in earnings per share: stronger than 77% of peers. Earnings per share growth: 52.3% vs peer median 9.8%
- faster revenue growth over the last year: stronger than 94% of peers. Revenue growth: 89.6% vs peer median 6.1%
- faster revenue growth over three years: stronger than 97% of peers. 3-year revenue growth: 116.2% vs peer median 5.8%
Metric by metric
Position: dot = ARGX, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | ARGX | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Revenue growthHigher is better · 56 reported | 89.6% | 9.6% | 100% | 33% | |
| Earnings per share growthHigher is better · 47 reported | 52.3% | 12.7% | 80% | 33% | |
| 3-year revenue growthHigher is better · 56 reported | 116.2% | 6.6% | 100% | 33% |
Ranking by growth score
Top 5 and the companies ranked around ARGX| Rank | Company | Market cap | Growth | Overall |
|---|---|---|---|---|
| 1 | 56.7B USD | 96 | 79 | |
| 2 | 40.2B USD | 92 | 73 | |
| 3 | 4.61T JPY (≈$31.3B) | 89 | 76 | |
| 4 | 43.30T KRW (≈$31.2B) | 86 | 68 | |
| 4 | 56.0B USD | 86 | 39 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score